Director/PDMR Shareholding
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your ONT notes
The Company has been notified that, on 6 March 2024, the following Directors and Persons Discharging Managerial Responsibilities (PDMRs) purchased the following ordinary shares in the Company:
| Name of PDMR | Number of ordinary shares | Price per ordinary share | ||||
| Nick Keher (Chief Financial Officer) | 77,975 | £1.275907 | ||||
| Dr Gordon Sanghera (Chief Executive Officer) | 15,467 | £1.292114 | ||||
| Dr Gordon Sanghera (Chief Executive Officer) | 39,196 | £1.274720 | ||||
| Dr Gordon Sanghera (Chief Executive Officer) | 23,737 | £1.262925 | ||||
| Duncan Tatton Brown (Chair) | 236,220 | £1.258663 | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Nicholas Keher | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Financial Officer | ||||
| b) | Initial/Amendment notification | Initial notification | ||||
| a) | Name | Oxford Nanopore Technologies plc | ||||
| b) | LEI | 213800IRWQ2Q6M2CDW55 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.0001 each GB00BP6S8Z30 | ||||
| b) | Nature of the transaction | Purchase of shares in the Company | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price | 77,975 £99,488.85 | ||||
| e) | Date of the transaction | 6 March 2024 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Dr Gurdial (Gordon) Sanghera | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Executive Officer | ||||
| b) | Initial/Amendment notification | Initial notification | ||||
| a) | Name | Oxford Nanopore Technologies plc | ||||
| b) | LEI | 213800IRWQ2Q6M2CDW55 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.0001 each GB00BP6S8Z30 | ||||
| b) | Nature of the transaction | Purchase of shares in the Company | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price | 15,467 £19,985.12 | ||||
| e) | Date of the transaction | 6 March 2024 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Dr Gurdial (Gordon) Sanghera | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Executive Officer | ||||
| b) | Initial/Amendment notification | Initial notification | ||||
| a) | Name | Oxford Nanopore Technologies plc | ||||
| b) | LEI | 213800IRWQ2Q6M2CDW55 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.0001 each GB00BP6S8Z30 | ||||
| b) | Nature of the transaction | Purchase of shares in the Company | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price | 39,196 £49,963.93 | ||||
| e) | Date of the transaction | 6 March 2024 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Dr Gurdial (Gordon) Sanghera | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Executive Officer | ||||
| b) | Initial/Amendment notification | Initial notification | ||||
| a) | Name | Oxford Nanopore Technologies plc | ||||
| b) | LEI | 213800IRWQ2Q6M2CDW55 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.0001 each GB00BP6S8Z30 | ||||
| b) | Nature of the transaction | Purchase of shares in the Company | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price | 23,737 £29,978.05 | ||||
| e) | Date of the transaction | 6 March 2024 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) | ||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Duncan Tatton-Brown | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chair | ||||
| b) | Initial/Amendment notification | Initial notification | ||||
| a) | Name | Oxford Nanopore Technologies plc | ||||
| b) | LEI | 213800IRWQ2Q6M2CDW55 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of £0.0001 each GB00BP6S8Z30 | ||||
| b) | Nature of the transaction | Purchase of shares in the Company | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Aggregated price | 236,220 £297,321.37 | ||||
| e) | Date of the transaction | 6 March 2024 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) |
[ENDS]
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.